PLX Total Liabilities
Protalix Biotherapeutics Inc · Total Liabilities
PLX Total Liabilities
Latest reported$38.93Mperiod ending
PLX Quarterly Total Liabilities ($7.30M → $38.93M)
Quarterly total liabilities
High-resolution chart · PNG
PLX total liabilities history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Total Liabilities (USD) |
|---|---|
| 38,932,000 | |
| 35,107,000 | |
| 34,116,000 | |
| 29,356,000 | |
| 28,583,000 | |
| 28,684,000 | |
| 30,206,000 | |
| 29,126,000 | |
| 62,959,000 | |
| 60,039,000 | |
| 50,865,000 | |
| 49,322,000 | |
| 49,416,000 | |
| 65,551,000 | |
| 66,427,000 | |
| 68,223,000 | |
| 70,529,000 | |
| 75,877,000 | |
| 79,701,000 | |
| 83,269,000 | |
| 104,363,000 | |
| 88,288,000 | |
| 94,971,000 | |
| 105,624,999 | |
| 106,474,000 | |
| 113,757,000 | |
| 115,714,000 | |
| 124,578,000 | |
| 122,727,000 | |
| 120,899,000 | |
| 114,012,000 | |
| 132,191,000 | |
| 101,292,000 | |
| 104,236,000 | |
| 103,507,000 | |
| 87,129,000 | |
| 79,668,000 | |
| 140,322,000 | |
| 92,204,000 | |
| 85,577,000 | |
| 86,840,000 | |
| 84,660,000 | |
| 86,380,000 | |
| 128,003,000 | |
| 131,091,000 | |
| 133,202,000 | |
| 134,071,000 | |
| 132,489,000 | |
| 136,441,000 | |
| 136,994,000 | |
| 140,279,000 | |
| 137,862,000 | |
| 74,292,000 | |
| 76,225,000 | |
| 82,084,000 | |
| 72,606,000 | |
| 76,441,000 | |
| 74,921,000 | |
| 77,882,000 | |
| 78,182,000 | |
| 80,591,000 | |
| 76,218,000 | |
| 76,052,000 | |
| 78,689,000 | |
| 75,784,000 | |
| 80,227,000 | |
| 82,788,000 | |
| 8,043,000 | |
| 7,270,000 | |
| 6,610,000 | |
| 6,464,000 | |
| 5,393,000 | |
| 5,307,000 | |
| 5,077,000 | |
| 4,452,000 | |
| 4,242,000 | |
| 3,262,000 | |
| 2,740,000 | |
| 2,704,000 | |
| 12,150 | |
| 13,480 | |
| 58,100 | |
| 72,930 | |
| 62,000 | |
| 57,785 | |
| 69,412 | |
| 70,474 | |
| 61,284 | |
| 67,438 | |
| 61,608 | |
| 78,823 | |
| 63,219 | |
| 61,707 | |
| 81,077 | |
| 79,074 | |
| 65,357 | |
| 61,417 | |
| 70,079 | |
| 77,276 | |
| 133,982 |